Patients’ experiences of prescribed anti-obesity drugs and perceptions of support from primary care: A qualitative study

Primary Health Care Research and Development

Volumn 11, Issue 3, 2010, Pages 250-259

  Psarou, Aikaterini ^a   Brown, Ian ^b  

^a UNIVERSITY OF CHESTER   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

anti obesity drugs; obesity; primary health care; qualitative research

Indexed keywords

EID: 85011438689     PISSN: 14634236     EISSN: 14771128     Source Type: Journal    
DOI: 10.1017/S1463423610000083     Document Type: Article

References (38)

1. Brown I., Thompson J., Tod A., Jones G. 2006: Primary care support for tackling obesity: a qualitative study of the perceptions of obese patients. British Journal of General Practice 56, 666–672. 16953998
2. Counterweight Project Team. 2005: Obesity impacts on general practice appointments. Obesity Research 13, 1442–1449.
3. Dalle Grave R., Calagi S., Magri F., Cuzzolaro M., Dall’Aglio E., Lucchin L., Melchionda N., Mrachesini G., the QUOVADIS Study Group. 2004: Weight loss expectations in obese patients seeking treatment at medical centres. Obesity Research 12, 2005–2012.
4. Department of Health. 2005: Choosing health: making healthy choices easier. London: The Stationary Office, Department of Health.
5. Department of Health. 2006: Care pathway for the management of overweight and obesity. London: Department of Health.
6. Department of Health. 2008: Healthy weight, healthy lives: a cross government strategy for England. Crown: Department of Health.
7. Dr Foster. 2005: Your guide to better health: primary care management of adult obesity. Retrieved June 2007 from http://www.drfosterintelligence.co.uk/library/reports/obesityManagement.pdf).
8. Elfhag K., Finer N., Rossner S. 2008: Who will lose weight on Sibutramine and Orlistat? Psychological correlates for treatment success. Diabetes, Obesity and Metabolism 10, 498–505.
9. Foresight. 2007: Tackling obesities: future choices – project report, Second edition. Government Office for Science. http://www.foresight.gov.uk
10. Foster G.D., Wadden T.A., Phelan S., Sarwer D.B., Sanderson R.S. 2001: Obese patients’ perceptions of treatment outcomes and the factors that influence them. Archives of Internal Medicine 161, 2133–2139.
11. Fox N.J., Ward K.J., O’Rourke A.J. 2005: The “expert patient”: empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. Social Science of Medicine 60, 1299–1309.
12. Franz M.J., VanWormer J.J., Crain L., Boucher J.L., Histon T., Caplan W., Bowman J.D., Pronk N.P. 2007: Weight-loss outcomes: a systematic review and meta-analysis of weight loss clinical trials with a minimum 1-year follow-up. Journal of American Dietetic Association 107, 1755–1767.
13. Gordon K., Smith F., Dhillon S. 2007: Effective chronic disease management: patients’ perspectives on medication-related problems. Patient Education and Counselling 65, 407–415.
14. Jeffrey R.W., Wing R.R., Randall R.M. 1998: Are smaller weight losses or more achievable weight loss goals better in the long-term for obese patients? Journal of Consulting Clinical Psychology 66, 641–645.
15. Lean M., Mullan A. 2007: Obesity: which drug and when? International Journal of Clinical Practice 61, 1555–1560.
16. Ley P. 1988: Communication with patients. London: Croom Held Ltd.
17. MHRA. 2008: MHRA Drug Alerts. Rimonabant (Acomplia): suspension of marketing authorisation as risks outweigh benefits. Retrieved 23 October 2008 from http://www.mhra.gov.uk
18. National Audit Office. 2001: Tackling obesity in England. London: The Stationary Office.
19. National Institute for Health and Clinical Excellence. 2006: Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE.
20. Nunes V., Neilson J., O’Flynn N., Calvert N., Kuntze S., Smithson H., et al 2009: Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
21. Ogden J., Sidhu S. 2006: Adherence, behaviour change and visualisation: a qualitative study of the experiences of taking an obesity medication. Journal of Psychosomatic Research 61, 545–552.
22. Padwal R.S., Majumdar S.R. 2007: Drug treatments for obesity: orlistat, sibutramine and rimonabant. Lancet 369, 71–77.
23. Potter M.B., Vu J.D., Croughan-Minihane M. 2001: Weight management: what patients want form their primary care physician. Journal of Family Practice 50, 513–518. 11401737
24. Pound P., Britten N., Morgan M., Yardley L., Pope C., Daker-White G., Campbell R. 2005: Resisting medicines: a synthesis of qualitative studies of medicine taking. Social Science of Medicine 61, 133–155.
25. Ramstrom H., Afandi S., Elofsson K., Petersson S. 2006: Differences in beliefs between patients and pharmaceutical specialists regarding medications. Patient Education and Counselling 62, 244–249.
26. Raynor D.K., Savage I., Knapp P., Henley J. 2004: We are the experts: people with asthma talk about their medicine information needs. Patient Education and Counselling 53, 167–174.
27. Richard C., Lussier M. 2006: Nature and frequency of exchanges on medications during primary care encounters. Patient Education and Counselling 64, 207–216.
28. Richie J., Lewis J. 2003: Qualitative research practice. London: Sage Publications.
29. Richie J., Spencer L., O’connor W. 2003: Carrying out qualitative analysis. In Richie, J. and Lewis, J., editor, Qualitative research practice, Ch 9. London: Sage Publications. 219–262.
30. Roberts A., Ashley G. 1999: What are the characteristics of overweight and obese patients who achieve weight loss and what factors are most helpful? A quantitative and qualitative study of patients and interventions in a rural general practice. Journal of Human Nutrition and Dietetics 12(Suppl 1), 20–27.
31. Rucker D., Padwal R., Li S.K., Curioni C., Lau D.C.W. 2007: Long term pharmacotherapy for obesity and overweight: updated meta analysis. British Medical Journal 335, 1194–1199.
32. SPC. 2007: Summary of product characteristics for reductil 10 mg and 15 mg. Retrieved November 2009 from http://emc.medicines.org.uk
33. SPC. 2006: Summary of product characteristics for acomplia 20 mg film-coated tablets. Retrieved June 2007 from http://emc.medicines.org.uk
34. SPC. 2009: Summary of product characteristics for xenical 120 mg hard capsules. Retrieved November 2009 from http://emc.medicines.org.uk
35. Staley K. 2009: Exploring impact: public involvement in NHS, Public Health and Social Care Research. Eastleigh: INVOLVE.
36. Tod A.M., Lacey A. 2004: Overweight and obesity: helping clients to take action. British Journal of Community Nursing 9, 59–66. 15007282
37. Townsend A., Hunt K., Wyke S. 2003: Managing multiple morbidity in mid-life: a qualitative study of attitudes to drug use. British Medical Journal 327, 837–842.
38. Wadden T.A., Womble L.G., Sarwer D.B., Berkowitz R.I., Clark V.L., Foster G.D. 2003: Great expectations: “I’m losing 25% of my weight no matter what you say”. Journal of Consulting Clinical Psychology 71, 1084–1089.